Last reviewed · How we verify
Diphtheria
Approved treatments
- Penicillin G Potassium In Plastic Container · Pfizer
- E-Mycin · Generic (originally Abbott/Lilly)
- Benzamycin · Pfizer
- penicillin · Karlstad University
Clinical guidelines
- FDA label — adj
Erythrocin Lactobionate-IV is indicated as an adjunct to antitoxin for the treatment of infections due to Corynebacterium diphtheriae to prevent establishment of carriers and to eradicate the organism in carriers.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Diphtheria patent landscape — cliff calendar, originator estates, attackable patents
- Diphtheria treatment landscape brief
- Diphtheria treatment updates RSS
Frequently asked questions about Diphtheria
What drugs treat Diphtheria?
Tracked treatments include Penicillin G Potassium In Plastic Container, E-Mycin, Benzamycin, penicillin.
What is the treatment for Diphtheria?
Standard treatment for Diphtheria includes Penicillin G Potassium In Plastic Container, E-Mycin, Benzamycin, penicillin. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Diphtheria?
FDA label publishes guidelines for Diphtheria. 1 guideline references tracked.
Related
- Treatment landscape: Diphtheria patent cliff · Diphtheria CI report
- Treatment: Penicillin G Potassium In Plastic Container · Pfizer
- Treatment: E-Mycin · Generic (originally Abbott/Lilly)
- Treatment: Benzamycin · Pfizer
- Treatment: penicillin · Karlstad University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing